Table 1.
Comparison of patients with AVFs or catheters as the vascular access.
| Fistula (N = 72) | Catheters (N = 32) | p | |
|---|---|---|---|
| Age | 63.1 ± 12.3 | 58.6 ± 16.7 | 0.128 |
| Gender (M/F) | 39/33 | 14/18 | |
| Diabetes (n, (%)) | 30 (41) | 7 (21) | 0.07 |
| Hypertension (n, (%)) | 56 (77) | 19 (59) | 0.06 |
| Other co-morbidities | |||
| CHF/IHD (n, (%)) | 47 (65) | 22 (68) | 0.82 |
| CVD (n, (%)) | 5 (7) | 5 (15) | 0.27 |
| Malignancies (n, (%)) | 4 (5) | 3 (9) | 0.67 |
| Mean arterial pressure (mmHg) | 94.9 ± 11.8 | 95.8 ± 13.2 | 0.72 |
| Albumin (g/dL) | 3.5 ± 0.3 | 3.3 ± 0.5 | 0.01 |
| Hemoglobin (g/dL) | 10.3 ± 1.5 | 9.6 ± 1.3 | 0.03 |
| Lymphocytes (per μL) | 1064 ± 517 | 978 ± 680 | 0.47 |
| Ferritin (ng/mL) | 843.0 ± 766.1 | 1586.2 ± 3669.6 | 0.11 |
| Peak ferritin (ng/mL) | 1193.6 ± 923.2 | 3307.1 ± 7699.4 | 0.02 |
| CRP (mg/L) | 80.9 ± 63.0 | 94.3 ± 68.5 | 0.33 |
| Peak CRP (mg/L) | 179.9 ± 108.1 | 217.4 ± 79.0 | 0.08 |
| Kt/V | 1.67 ± 0.54 | 1.60 ± 0.74 | 0.55 |
| Time spent in dialysis (months) | 65.2 ± 40.5 | 34.9 ± 31.7 | 0.00 |
| COVID severity | 2.42 ± 0.80 | 2.72 ± 0.95 | 0.09 |
| Lung involvement (n, (%)) | 68 (94) | 27 (84) | 0.23 |
| Hospital stay length (days) | 8.6 ± 3.9 | 19.0 ± 18.3 | 0.00 |
| ICU requirement (n, (%)) | 22 (30.5) | 13 (40) | 0.37 |
| In hospital mortality (n, (%)) | 22 (30.5) | 16 (50) | 0.07 |
AVF: arterio-venous fistula; M: male; F: female; CHF: congestive heart failure; IHD: ischemic heart disease; CVD: cerebrovascular disease; ICU: intensive care unit.